Haumann Brett K

Chief Medical Officer at TBPH

Sold, on record
$1.3M
Dollars the filings state
Form 4 sales
4
Latest Aug 21, 2020
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • TBPHTheravance Biopharma, Inc.Chief Medical Officer

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale TBPHPlan not stated
    Aug 19, 2016 2016

    Sold 9,509 shares at $27.97 ($266k)

    Haumann Brett K, SVP Clin Dev & Chief Med Ofc

    Sold 4.6% of holdings ($5.8M position)197,391 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale TBPHPlan not stated
    Aug 25, 2016 +6 days

    Sold 4,491 shares at $27.99 ($126k)

    Haumann Brett K, SVP Clin Dev & Chief Med Ofc

    Sold 2.3% of holdings ($5.4M position)188,293 shares leftFiling

  3. 3 Form 4 sale TBPHPlan not stated
    Mar 7, 2017 +194 days

    Sold 14,000 shares at $31.50 ($441k)

    Haumann Brett K, SVP Clin Dev & Chief Med Ofc

    Sold 7.9% of holdings ($5.6M position)163,471 shares leftFiling

  4. 4 Form 4 sale TBPHPlan not stated
    Aug 21, 2020 +1263 days

    Sold 25,000 shares at $18.29 ($457k)

    Haumann Brett K, Chief Medical Officer

    Sold 8.1% of holdings ($5.6M position)282,810 shares leftFirst sale on recordFiling

Every transaction

Loading transactions…

Sales and notices (4)

Form 144 notices and Form 4 sales by Haumann Brett K
Source
Aug 21, 2020Aug 24, 2020TBPHChief Medical OfficerForm 4 sale25,000$457k8.1%Plan not statedSEC
Mar 7, 2017Mar 8, 2017TBPHSVP Clin Dev & Chief Med OfcForm 4 sale14,000$441k7.9%Plan not statedSEC
Aug 25, 2016Aug 25, 2016TBPHSVP Clin Dev & Chief Med OfcForm 4 sale4,491$126k2.3%Plan not statedSEC
Aug 19, 2016Aug 23, 2016TBPHSVP Clin Dev & Chief Med OfcForm 4 sale9,509$266k4.6%Plan not statedSEC